Trial Outcomes & Findings for A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer (NCT NCT02182804)

NCT ID: NCT02182804

Last Updated: 2020-08-28

Results Overview

Diagnostic performance of the pCLE and M-NBI in Lugol's voiding lesions size larger than 5 millimeters.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

44 participants

Primary outcome timeframe

an expected average of 2 weeks

Results posted on

2020-08-28

Participant Flow

There were 631 patients with a previous history of head and neck cancer in the 10-year record. Of the 631 patients, 587 were excluded for the following reasons: patients could not be contacted (n=458), death (n=72), esophageal obstruction or stricture, previous esophageal surgery (n=34), and patients who refused to participate (n=23).

Participant milestones

Participant milestones
Measure
Study Arm
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
Overall Study
STARTED
44
Overall Study
COMPLETED
44
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Study Arm
n=44 Participants
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
Age, Continuous
60 years
STANDARD_DEVIATION 12 • n=44 Participants
Sex: Female, Male
Female
6 Participants
n=44 Participants
Sex: Female, Male
Male
38 Participants
n=44 Participants
Region of Enrollment
Thailand
44 Participants
n=44 Participants

PRIMARY outcome

Timeframe: an expected average of 2 weeks

Population: Twenty-one Lugol's voiding lesions larger than 5mm were detected in 12 patients.

Diagnostic performance of the pCLE and M-NBI in Lugol's voiding lesions size larger than 5 millimeters.

Outcome measures

Outcome measures
Measure
Study Arm
n=21 Lugol's voiding lesion
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
Accuracy
dNBI
70 Percentage of accuracy
Interval 48.0 to 85.0
Accuracy
pCLE
89 Percentage of accuracy
Interval 67.0 to 97.0

Adverse Events

Study Arm

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Study Arm
n=44 participants at risk
Probe-based confocal laser endomicroscopy and narrow band imaging with magnification in esophageal Lugol's voiding lesions.
Surgical and medical procedures
Bleeding
2.3%
1/44 • Number of events 1 • Intraprocedural.

Additional Information

Dr. Piyapan Prueksapanich

Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.

Phone: 6622564000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place